Merkel cell cancer overview: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
From initial onset, Merkel cell cancer [[metastasize]]s quickly and spreads to other parts of the body, tending towards the regional [[lymph nodes]]. The tumor tends to invade underlying subcutaneous [[Adipose tissue|fat]], [[fascia]], and [[muscle]]. It can also metastasize to the [[liver]], [[lungs]], [[brain]] or [[bone]]s. | From initial onset, Merkel cell cancer [[metastasize]]s quickly and spreads to other parts of the body, tending towards the regional [[lymph nodes]]. The tumor tends to invade underlying subcutaneous [[Adipose tissue|fat]], [[fascia]], and [[muscle]]. It can also metastasize to the [[liver]], [[lungs]], [[brain]] or [[bone]]s. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Merkel cell polyomavirus, the pathogen responsible for Merkel cell cancer, was first discovered in 2008.<ref name="pmid23217622">{{cite journal| author=Spurgeon ME, Lambert PF| title=Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. | journal=Virology | year= 2013 | volume= 435 | issue= 1 | pages= 118-30 | pmid=23217622 | doi=10.1016/j.virol.2012.09.029 | pmc=PMC3522868 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23217622 }} </ref> | |||
==Classification== | ==Classification== | ||
Mercell cell carcinoma is classified into 3 subgroups: trabecular, intermediate, and small cell. | |||
==Pathophysiology== | ==Pathophysiology== | ||
==Causes== | ==Causes== | ||
Merkel cell cancer is caused by Merkel cell polyomavirus (MCV) infection. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Merkel cell cancer must be differentiated from other skin lesions, such as [[basal cell carcinoma]], [[squamous cell carcinoma]], [[malignant melanoma]], [[lymphoma]], vascular tumors, and other benign skin tumors. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The incidence of Merkel cell carcinoma ranges from 0.15 to 0.44 per 100,000 individuals. The median age at diagnosis is approximately 65 years. Merkel cell carcinoma is more common among males and individuals of Caucasian race. | |||
==Risk Factors== | ==Risk Factors== | ||
Risk factors for the development of Merkel cell cancer include old age, male gender, Caucasian race, chronic exposure to sunlight, immunodeficiency, and personal history of cancer. | |||
==Screening== | ==Screening== | ||
Screening for Merkel cell cancer is not recommended. | |||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
Merkel cell carcinoma is a highly aggressive tumor with a mortality rate that approaches 30% to 40% within 3 years of diagnosis. If diagnosed early, Merkel cell cancer has a good prognosis with a 5-year survival rate of approximately 90%. | |||
==Diagnosis== | ==Diagnosis== | ||
===Staging=== | ===Staging=== |
Revision as of 02:03, 21 August 2015
Merkel cell cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Merkel cell cancer overview On the Web |
American Roentgen Ray Society Images of Merkel cell cancer overview |
Risk calculators and risk factors for Merkel cell cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Merkel cell cancer is a rare and highly aggressive cancer where malignant cancer cells develop on or just beneath the skin and in hair follicles. This cancer is a type of neuroendocrine tumor, like small cell lung cancer. Merkel cell carcinoma is the most serious form of skin cancer. Once it has metastasized to the lymph nodes, the 5-year survival rate for a patient is about 50 percent. A small tumor (less than 2 cm) that has not metastasized to the lymph nodes reported a 5-year survival rate of more than 90 percent; however, at the time of diagnosis of MCC the 5-year survival was 64 percent. Recurrence can occur in up to half of all patients. [1]
It occurs most often on the face, head, and neck. It usually appears as firm, painless, nodules, or tumors. These flesh-colored, red, or blue tumors vary in size from 5 mm (less than a quarter of an inch) to more than 5cm (2 inches). The tumor grows rapidly. About half of all Merkel cell cancers occur on the sun-exposed areas of the head and neck, while one-third begin on the legs, and 15% occur on the arms. The cancer may also begin on other parts of the body, such as the trunk.
From initial onset, Merkel cell cancer metastasizes quickly and spreads to other parts of the body, tending towards the regional lymph nodes. The tumor tends to invade underlying subcutaneous fat, fascia, and muscle. It can also metastasize to the liver, lungs, brain or bones.
Historical Perspective
Merkel cell polyomavirus, the pathogen responsible for Merkel cell cancer, was first discovered in 2008.[2]
Classification
Mercell cell carcinoma is classified into 3 subgroups: trabecular, intermediate, and small cell.
Pathophysiology
Causes
Merkel cell cancer is caused by Merkel cell polyomavirus (MCV) infection.
Differential Diagnosis
Merkel cell cancer must be differentiated from other skin lesions, such as basal cell carcinoma, squamous cell carcinoma, malignant melanoma, lymphoma, vascular tumors, and other benign skin tumors.
Epidemiology and Demographics
The incidence of Merkel cell carcinoma ranges from 0.15 to 0.44 per 100,000 individuals. The median age at diagnosis is approximately 65 years. Merkel cell carcinoma is more common among males and individuals of Caucasian race.
Risk Factors
Risk factors for the development of Merkel cell cancer include old age, male gender, Caucasian race, chronic exposure to sunlight, immunodeficiency, and personal history of cancer.
Screening
Screening for Merkel cell cancer is not recommended.
Natural History, Complications and Prognosis
Merkel cell carcinoma is a highly aggressive tumor with a mortality rate that approaches 30% to 40% within 3 years of diagnosis. If diagnosed early, Merkel cell cancer has a good prognosis with a 5-year survival rate of approximately 90%.
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
References
- ↑ Allen PJ, Browne WB, Jaques DP; et al. (2005). "Merkel cell carcinoma: Prognosis and treatment of patients from a single institution". Journal of Clinical Oncology. 23 (10): 2300–2309.
- ↑ Spurgeon ME, Lambert PF (2013). "Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential". Virology. 435 (1): 118–30. doi:10.1016/j.virol.2012.09.029. PMC 3522868. PMID 23217622.